Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE).

Authors

Hisham Mehanna

Hisham Mohamed Mehanna

University of Birmingham, Birmingham, United Kingdom

Hisham Mohamed Mehanna , Mehmet Sen , John David Chester , Paul Sanghera , Vinidh Paleri , Piers Gaunt , Jaspreet Babrah , Andrew G. J. Hartley , Anthony Kong , H Al-Booz , Bernadette Foran , Elizabeth Miles , Max Robinson , Marcus Jepson , Jenny Donnovan , Christina Yap , Charlotte Firth , Claire Gaunt , Sarah Jane Bowden , Martin David Forster

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

41478539

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS6091)

DOI

10.1200/JCO.2017.35.15_suppl.TPS6091

Abstract #

TPS6091

Poster Bd #

78b

Abstract Disclosures